GGrantIndex
Sort

53,477 grants matching addiction

Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System

$2,663,604
Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES

Defining neurobiological links between substance use and mental illness

$2,662,876
Amy Janes · National Institute On Drug Abuse · ZIA · FY2024 · DA

Frontal Striatal Systems and Dopamine in Normal and Pathological Behavior

$2,661,668
Bruno Averbeck · National Institute Of Mental Health · ZIA · FY2022 · MH

Characterization of neuronal ensembles activated during cue-induced reward seeking

$2,655,574
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2022 · DA

Strategies to define and mitigate the placental and fetal alterations caused by maternal oxycodone exposure

$2,655,006
Lynda Katherine Harris · University Of Nebraska Medical Center · R01 · FY2023 · DA

Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice

$2,654,681
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · DA

HIV Prevention Trials Network: Network Laboratory

$2,654,477
Susan H Eshleman · Johns Hopkins University · U01 · FY2010 · AI

HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake

$2,653,218
Faye S Taxman · George Mason University · OT2 · FY2022 · OD

Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers

$2,652,771
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2025 · DA

Chicago WIHS Consortium V (CWC)

$2,651,955
Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2014 · AI

Harvard PRECISION Human Pain Center

$2,647,394
William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2022 · NS

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Humans

$2,646,398
George R Uhl · National Institute On Drug Abuse · Z01 · FY2007 · DA

Preclinical studies for the development of selective mGlu2 positive allosteric modulators to treat substance use disorders

$2,646,217
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2017 · DA

Center for Methodologies for Adapting and Personalizing Prevention, Treatment and Recovery Services for SUD and HIV (MAPS Center)

$2,644,185
Inbal Billie Nahum-Shani · University Of Michigan At Ann Arbor · P50 · FY2023 · DA

Preclinical Evaluation Of PET Radiotracers

$2,642,722
Robert Innis · National Institute Of Mental Health · ZIA · FY2010 · MH

ABCD-USA Consortium: Twin Research Project

$2,641,542
William G Iacono · University Of Minnesota · U01 · FY2015 · DA

HEALTH Center for Addictions Research and Cancer Prevention

$2,641,252
Ezemenari M Obasi · University Of Houston · U54 · FY2020 · MD

Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice

$2,641,224
Paul J Kenny · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · DA

Neurotoxicity in the adult rat following chronic exposure to methamphetamine

$2,638,252
Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2025 · DA

VA-Perry Point Cooperative Studies Program

$2,636,720
National Institute On Drug Abuse · Y01 · FY2014 · DA

Pharmacogenetics of Nicotine Addiction Treatment

$2,635,621
Caryn Lerman · University Of Pennsylvania · U01 · FY2012 · DA

Clinical Trials Network, Ohio Valley Node

$2,634,865
Eugene C. Somoza · University Of Cincinnati · U10 · FY2007 · DA

Functional Magnetic Resonance Imaging Of Emotion As Related To Alcoholism

$2,633,678
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

Integrated GWAS of complex behavioral and gene expression traits in outbred rats

$2,632,209
Abraham A Palmer · University Of California, San Diego · P50 · FY2016 · DA

Support for Enhancement Excellence in Research at UPR RP

$2,631,086
University Of Puerto Rico Rio Piedras · S06 · FY2004 · GM